https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients who undergo liver transplantation (LT). Whereas there is huge data on NAFLD, little is known about NAFLD in LT. In this review, we aim to explore extrahepatic organs and their potential mechanisms in the development of NAFLD in LT patients and discuss current limitations in preclinical and clinical scenarios with suggestions for future study. The following keywords, such as NAFLD, NASH, liver transplant, therapy, pathogenesis and biomarkers, were set for l
Like
Comment
Share
